Exploiting ferroptosis vulnerabilities in cancer

Toshitaka Nakamura1, Marcus Conrad2

  • 1Institute of Metabolism and Cell Death, Molecular Targets & Therapeutics Center, Helmholtz Munich, Neuherberg, Germany.

Nature Cell Biology
|June 10, 2024
PubMed

Insights

Ferroptosis, a cell death form, is a promising cancer therapy target. Understanding its mechanisms and modulation is key to developing new treatments for difficult-to-treat cancers.

Area of Science:

  • Biochemistry and Molecular Biology
  • Cell Death Mechanisms
  • Cancer Therapeutics

Background:

  • Ferroptosis is a regulated form of cell death driven by lipid peroxidation.
  • Cancer cells, particularly difficult-to-treat types and those in specific microenvironments, exhibit vulnerability to ferroptosis.
  • Targeting ferroptosis presents a novel therapeutic strategy in oncology.

Purpose of the Study:

  • To review recent advancements in the molecular mechanisms of ferroptosis.
  • To highlight tools for modulating ferroptosis sensitivity in cancer cells.
  • To discuss the interplay between ferroptosis and the tumor immune microenvironment.

Main Methods:

  • Literature review of recent scientific publications on ferroptosis.
  • Analysis of molecular pathways regulating ferroptosis.
  • Evaluation of therapeutic strategies targeting ferroptosis.

Main Results:

  • Detailed understanding of ferroptosis's molecular underpinnings has advanced significantly.
  • Various tools exist to modulate ferroptosis sensitivity in cancer cells.
  • Ferroptosis influences communication within the tumor microenvironment, including with immune cells.

Conclusions:

  • Ferroptosis is a viable and emerging target for cancer therapy.
  • Modulating ferroptosis pathways offers new avenues for overcoming treatment resistance.
  • Further research into ferroptosis activation pathways can enhance cancer treatment strategies.

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K